|
1.
|
Elzinga BM, Nyhan MJ, Crowley LC,
O’Donovan TR, Cahill MR and McKenna SL: Induction of autophagy by
Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates
Bcr-Abl protein. Am J Hematol. 88:455–462. 2013. View Article : Google Scholar
|
|
2.
|
Cortez D, Reuther G and Pendergast AM: The
Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and
stimulates G1-to-S phase transition in hematopoietic cells.
Oncogene. 15:2333–2342. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Yang X, Lin J, Gong Y, et al:
Antileukaemia effect of rapamycin alone or in combination with
daunorubicin on ph+ acute lymphoblastic leukaemia cell line.
Hematol Oncol. 30:123–130. 2012.
|
|
4.
|
Carew JS, Nawrocki ST, Giles FJ and
Cleveland JL: Targeting autophagy: a novel anticancer strategy with
therapeutic implications for imatinib resistance. Biologics.
2:201–204. 2008.
|
|
5.
|
Burchert A: Roots of imatinib resistance:
a question of self-renewal? Drug Resist Updat. 10:152–161. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Yang ZJ, Chee CE, Huang S and Sinicrope
FA: The role of autophagy in cancer: therapeutic implications. Mol
Cancer Ther. 10:1533–1541. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Yu Y, Yang L, Zhao M, et al: Targeting
microRNA-30a-mediated autophagy enhances imatinib activity against
human chronic myeloid leukemia cells. Leukemia. 26:1752–1760. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Bellodi C, Lidonnici MR, Hamilton A, et
al: Targeting autophagy potentiates tyrosine kinase
inhibitor-induced cell death in Philadelphia chromosome-positive
cells, including primary CML stem cells. J Clin Invest.
119:1109–1123. 2009. View
Article : Google Scholar
|
|
9.
|
Crowley LC, Elzinga BM, O’Sullivan GC and
McKenna SL: Autophagy induction by Bcr-Abl-expressing cells
facilitates their recovery from a targeted or nontargeted
treatment. Am J Hematol. 86:38–47. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Liu J, Xia H, Kim M, et al: Beclin1
controls the levels of p53 by regulating the deubiquitination
activity of USP10 and USP13. Cell. 147:223–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Zhao M, Yang M, Yang L, et al: HMGB1
regulates autophagy through increasing transcriptional activities
of JNK and ERK in human myeloid leukemia cells. BMB Rep.
44:601–606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Salomoni P and Calabretta B: Targeted
therapies and autophagy: new insights from chronic myeloid
leukemia. Autophagy. 5:1050–1051. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Mishima Y, Terui Y, Taniyama A, et al:
Autophagy and autophagic cell death are next targets for
elimination of the resistance to tyrosine kinase inhibitors. Cancer
Sci. 99:2200–2208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yu Y, Cao L, Yang L, Kang R, Lotze M and
Tang D: microRNA 30A promotes autophagy in response to cancer
therapy. Autophagy. 8:853–855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Sheng Z, Ma L, Sun JE, Zhu LJ and Green
MR: BCR-ABL suppresses autophagy through ATF5-mediated regulation
of mTOR transcription. Blood. 118:2840–2848. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Tong Y, Liu YY, You LS and Qian WB:
Perifosine induces protective autophagy and upregulation of ATG5 in
human chronic myelogenous leukemia cells in vitro. Acta Pharmacol
Sin. 33:542–550. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Burchert A, Wang Y, Cai D, et al:
Compensatory PI3-kinase/Akt/mTor activation regulates imatinib
resistance development. Leukemia. 19:1774–1782. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Frame S, Cohen P and Biondi RM: A common
phosphate binding site explains the unique substrate specificity of
GSK3 and its inactivation by phosphorylation. Mol Cell.
7:1321–1327. 2001. View Article : Google Scholar
|
|
19.
|
Linke R and Dempke W: Management of
imatinib-resistant CML patients. Onkologie. 30:574–580. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Drullion C, Tregoat C, Lagarde V, et al:
Apoptosis and autophagy have opposite roles on imatinib-induced
K562 leukemia cell senescence. Cell Death Dis. 3:e3732012.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Drullion C, Lagarde V, Gioia R, et al:
Mycophenolic acid overcomes imatinib and nilotinib resistance of
chronic myeloid leukemia cells by apoptosis or a senescent-like
cell cycle arrest. Leuk Res Treatment. 2012.8613012012.PubMed/NCBI
|
|
22.
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Han W, Sun J, Feng L, et al: Autophagy
inhibition enhances daunorubicin-induced apoptosis in K562 cells.
PLoS One. 6:e284912011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Kuroda J, Shimura Y, Yamamoto-Sugitani M,
Sasaki N and Taniwaki M: Multifaceted mechanisms for cell survival
and drug targeting in chronic myelogenous leukemia. Curr Cancer
Drug Targets. 13:69–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
McCubrey JA, Steelman LS, Abrams SL, et
al: Targeting survival cascades induced by activation of
Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for
effective leukemia therapy. Leukemia. 22:708–722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
McCubrey JA, Steelman LS, Bertrand FE, et
al: Multifaceted roles of GSK-3 and Wnt/beta-catenin in
hematopoiesis and leukemogenesis: opportunities for therapeutic
intervention. Leukemia. 28:15–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Chiara F and Rasola A: GSK-3 and
mitochondria in cancer cells. Front Oncol. 3:162013. View Article : Google Scholar
|
|
28.
|
Maurer U, Charvet C, Wagman AS, Dejardin E
and Green DR: Glycogen synthase kinase-3 regulates mitochondrial
outer membrane permeabilization and apoptosis by destabilization of
MCL-1. Mol Cell. 21:749–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Morel C, Carlson SM, White FM and Davis
RJ: Mcl-1 integrates the opposing actions of signaling pathways
that mediate survival and apoptosis. Mol Cell Biol. 29:3845–3852.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Wang R, Xia L, Gabrilove J, Waxman S and
Jing Y: Down-regulation of Mcl-1 through GSK-3beta activation
contributes to arsenic trioxide-induced apoptosis in acute myeloid
leukemia cells. Leukemia. 27:315–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
